IR Banner

Posters & Publications

Date Title View
Jun 03, 2024
ENDO 2024 Late-Breaking Poster Presentation – Growth Response to Oral GH Secretagogue LUM-201 in Children with Moderate GHD is Dependent on the Pattern of Pulsatile GH Secretion Stimulated by LUM-201
Jun 03, 2024
ENDO 2024 Poster Presentation – Oral LUM-201 Restores Pulsatile GH Secretion and Growth Response in Moderate PGHD – Key Discoveries from Phase 2 OraGrowtH212 Trial
May 12, 2024
ECE 2024 Poster Presentation – Restoring GH Secretion and Growth with Oral LUM-201 in Moderate PGHD
May 10, 2024
GRS 2024 Oral Presentation – Restoring GH Secretion and Growth with Oral LUM-201 in Moderate PGHD
May 03, 2024
PES 2024 Poster Presentation – Oral LUM-201 Shows Similar Growth to rhGH in Moderate PGHD
Sep 23, 2023
ESPE 2023 Oral Presentation – Deconvolution Analysis: Oral LUM-201 Enhances Growth in PGHD by Enhancing Endogenous GH Secretion & Increasing IGF-1
Jun 17, 2023
ENDO 2023 Oral Presentation - Growth Response of Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD): Combined Analysis Interim Analysis Data
Jun 17, 2023
ENDO 2023 Oral Presentation - LUM-201 Dose Response Measured by Acute GH, IGF-1, and Annualized Height Velocity (AHV) from Interim Analysis of OraGrowtH212 Trial in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD)
May 07, 2023
PES 2023 Poster - Observed IGF-1 Serum Concentration Increase Within Normal Range After Prolonged Daily Oral LUM-201 Administration in Idiopathic Pediatric Growth Hormone Deficiency from the OraGrowtH212 Trial: Interim Analysis Data
May 07, 2023
PES 2023 Oral Presentation - Growth Response to LUM-201 in the OraGrowtH210 Trial in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD): Interim Analysis Data (41 Subjects)
Mar 05, 2023
IMPE 2023 Poster – Baseline Demographics of the OraGrowtH210 Trial Studying LUM-201 in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD) Interim Analysis Data
Mar 05, 2023
IMPE 2023 Oral Presentation – Dose-dependent Increase in GH AUC0-12h with LUM-201 in Idiopathic Pediatric GH Deficiency (iPGHD) from the Interim Analysis Data of the OraGrowtH212 Trial
Mar 30, 2022
A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial
Mar 20, 2021
LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency
Mar 04, 2021
Development of a Predictive Enrichment Marker for Oral GH Secretagogue LUM-201 in Children with Growth Hormone Deficiency
Mar 04, 2021
Corroboration of Height Velocity Prediction Markers for rhGH with an Oral GH Secretagogue Treatment in Children with GHD
Email Alerts Subscription
Download Library
Print
Share
Search Investors